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Introduction
Raynaud Phenomenon (RP) and digital ulcers (DU) are the
main clinical manifestation of vasculopathy secondary to
Juvenile Systemic Sclerosis (jSSc) . Accepted treatment for
RP is calcium channel blockers. Iloprost is indicated if
active ulcers are present or if RP is refractory to treatment.
Objectives
The aim of this study was to access the safety and efficacy
of ambulatory treatment with intravenous prostanoides
in children with RP and DU secondary to jSSc.
Methods
Three patients with jSSc and active digital ulcers were
treated with intravenous iloprost . Our protocol estab-
lishes two treatments in the cold months: one in the
beginning and the second 3 months later, of a continu-
ous five day intravenous infusion(iv) of iloprost in a
dose of 0.4- 0,6 mg/kg/min perfusion through an elasto-
meric pump
Results
Since 2007 we treated three patients with jSSc and
active digital ulcers: two girls, 12 and 13 years, and a
boy of 18 months old at time of first treatment. A total
of 19 treatments of iv. iloprost were done, 15 of these in
ambulatory basis with the elastomeric pump
Outcomes were good with a reduced number and
severity of RP attacks in all patients, and reduced pain
associated with RP and DU. No disabling or severe side
effects were observed. Two patients, the girls, had no
more active digital ulcers after the second treatment
with a follow-up of 2 and 3 years respectively. One
patient, male, has recurrent digital ulcers, but number
has decreased from 4 to 1 not interfering with daily
activities.
Conclusion
Iloprost iv. perfusion with the elastomeric pump at ambu-
latory is a safe and effective treatment for patients with
refractory RP to calcium channel blockers and in patients
with digital ulcers. The authors suggest two treatments in
the winter season with reduction of number and severity
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